3rd PREDiCT Tumor Models San Francisco

3rd PREDiCT Tumor Models San Francisco is organized by Hanson Wade and will be held from Jan 22 - 24, 2019 at Hotel Kabuki, San Francisco, California, United States of America.

Conference Description:
Returning for its 3rd year, PREDiCT: Tumor Models San Francisco remains dedicated to revealing model-based strategies adding immediate value to emerging IO programs.

With new speakers, fresh case studies, and a more interactive format to the agenda, this is your opportunity to plug into a ready-made network of pioneering biotech and developers redefining this area.

Leave with actionable takeaways on model utility and applicability. Dive into the use of both emerging and classical model systems and understand how they can correctly be used to support your translational decision making.

Why Attend?
Where other conferences require you sit and listen quietly, we’ve redesigned the meeting format to ensure interactivity throughout and make sure you’ll leave with actionable takeaways on model utility and applicability.

With new speakers, fresh case studies, and a more interactive format to the meeting agenda, this is your opportunity to join a dedicated and multidisciplinary mix of pharmaceutical scientists in exploring model-based strategies adding immediate value to IO programmes.

So, whether you’re looking to benchmark your model approach or are seeking to explore new systems and technologies, Tumour Models San Francisco offers you a unique opportunity to plug into a ready-made network of peers who continue to redefine this area and have already solved the variety of challenges you’re facing.

Speakers:
James Hodge, Deputy Chief Tumor Immunology and Biology, Senior Investigator, Head, Recombinant Vaccine Group, National Cancer Institute, Barbara Joyce- Shaikh, Associate Principal Scientist, Merck and Co, Peter King, Principal Scientist PDS-PDM - Imaging, Janssen Research and Development, John Westwick, CEO, Resonant Therapeutics, Inc, Joshua Breunig, Associate Professor and Board of Governors Regenerative Medicine, Cedars-Sinai Medical Center.

 Additional details will be posted as soon as they are available.